Expression Pathology, Oridis to Offer Protein-Biomarker Services | GenomeWeb
NEW YORK (GenomeWeb News) — Expression Pathology has formed an alliance with the Austrian company Oridis Biomed to offer proteomic tissue-analysis services for protein biomarker research, the companies said today.
 
Under the agreement, both companies will be able to offer the collaborative research services to clients in the drug-development, medical-diagnostic, and academic spheres.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.